Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man. 1974

W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007444 Inulin A starch found in the tubers and roots of many plants. Since it is hydrolyzable to FRUCTOSE, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function.
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age

Related Publications

W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
September 1979, European journal of clinical pharmacology,
W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
January 1987, European journal of clinical pharmacology,
W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
January 1983, British journal of clinical pharmacology,
W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
June 1976, European journal of clinical investigation,
W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
December 1978, European journal of clinical pharmacology,
W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
November 1965, Arzneimittel-Forschung,
W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
May 1972, Journal of pharmaceutical sciences,
W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
January 1969, Journal of applied physiology,
W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
February 1959, The Journal of clinical endocrinology and metabolism,
W Lintz, and W Berger, and W Aenishaenslin, and V Kutova, and C Baerlocher, and J P Kapp, and R Beckmann
July 1971, Toxicology and applied pharmacology,
Copied contents to your clipboard!